ゆうゆうと
liked
$Gyre Therapeutics (GYRE.US)$
I don't think the parent company would go out of their way to just post this Q&A...
do you want to smell the te◯ ke ◯?
gnipharma.com/ i...
I don't think the parent company would go out of their way to just post this Q&A...
do you want to smell the te◯ ke ◯?
gnipharma.com/ i...
Translated
14
ゆうゆうと
commented on
$Gyre Therapeutics (GYRE.US)$
If the Blue-Eyes join the battle
It's not even close 🚀
Is the mega partnership finally coming⁉️🚀🚀🚀
Wait until payday 💦
If the Blue-Eyes join the battle
It's not even close 🚀
Is the mega partnership finally coming⁉️🚀🚀🚀
Wait until payday 💦
Translated
7
3
ゆうゆうと
commented on
5
5
ゆうゆうと
liked and commented on
$Gyre Therapeutics (GYRE.US)$
年末までにIND申請予定ゆえ、あるとすれば秋頃までに提携と踏んでますー🚀
6/28のラッセル入り以降は毎日ソワソワカウントダウンしときます笑
このまま出来高なく低空飛行が続くなら微足しし続けますー (´ω｀)
年末までにIND申請予定ゆえ、あるとすれば秋頃までに提携と踏んでますー🚀
6/28のラッセル入り以降は毎日ソワソワカウントダウンしときます笑
このまま出来高なく低空飛行が続くなら微足しし続けますー (´ω｀)
10
3
I just can't add it. I can't use bonuses without permission either 
I was still able to jump in if I was single 
$Gyre Therapeutics (GYRE.US)$
My parents have started moving, so maybe this one is about to catch fire too 😚 or tonight too 🥲? Anyway, I'll wait forever 😗
My parents have started moving, so maybe this one is about to catch fire too 😚 or tonight too 🥲? Anyway, I'll wait forever 😗
Translated
8
3
ゆうゆうと
liked
$Gyre Therapeutics (GYRE.US)$ I hope the gradual increase continues every day like it is now, even if it's just a few percent.
Translated
11
ゆうゆうと
liked
$Gyre Therapeutics (GYRE.US)$ 余力少ないのでちまちま微追加してますが、まさか10ドルくらいで買えるとは思いませんでした😅旧ニーサの取得単価に近づいてきました💧言うまでもなく特定や新ニーサの取得単価の半値くらいになってます😢
正直言って安値で足せるのは嬉しい。
がしかし、ガッツリ買えない余力事情が悲しい...😓
89バイオ少し処分してジャイ子追加に動きますー😂
正直言って安値で足せるのは嬉しい。
がしかし、ガッツリ買えない余力事情が悲しい...😓
89バイオ少し処分してジャイ子追加に動きますー😂
11
1
ゆうゆうと
commented on
$Gyre Therapeutics (GYRE.US)$The earnings reports for the first quarter of 2024 were extremely good, so why are they down now? Is it necessary for the main board's GNI to announce their earnings reports? It seems like the main board is also restraining stock price manipulation by institutions, but there are rumors going around. It is said that going to the main board is a good idea, but it seems that relying on 351 is still the way to go.
Translated
14
2
ゆうゆうと
commented on
$Gyre Therapeutics (GYRE.US)$
Since it's a license agreement for GYRE's subsidiary, I'd like GYRE to IR too...
Company News - Beijing Contini Pharmaceutical Co., Ltd.
Since it's a license agreement for GYRE's subsidiary, I'd like GYRE to IR too...
Company News - Beijing Contini Pharmaceutical Co., Ltd.
Translated
9
2
$Gyre Therapeutics (GYRE.US)$ Is it another case of the major shareholder's sell-off as usual?
Translated
8
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)